News About: Pharm. Industry
Infopia, Roche Diagnostic Korea sign patent-sharing deal
Infopia has signed an agreement with Roche Diagnostics Korea’s diabetic management division to share Roche’s patented technology, the Korean company said Tuesday.
Through the agreement, Infopia will obtain access t...
CJ’s Exone eyeing bigger market share
CJ Cheil Jedang is striving to expand its share of the domestic hypertension combination drug market dominated by international drugmakers.
Exone, CJ’s new incrementally modified drug (IMD) containing valsartan ...
Wholesalers calling for government to drop cash reward system
The Korea Pharmaceutical Wholesaler Association (KPWA) on Monday said the contentious cash reward system for doctors and pharmacists should be scrapped to prevent the collapse of the local pharmaceutical industry and ...
Combination therapies for hypertension enjoy robust sales
Major drug makers, who have been marketing combined formulations of ARB+CCB for the treatment of hypertension, enjoyed robust sales growth last year, industry data showed.
According to the data released by the Ubis...
Ildong to turn into holding company
Ildong Pharmaceutical said Monday it plans to split the company into two parts of holding and operating firms in an effort to streamline the corporate structure from this year.
A board of directors finalized the p...
Siemens, Eulji University sign MOU
Siemens Healthcare Korea on Monday signed a memorandum of understanding (MOU) with Eulji Hospital in a bid to foster global brains in the local health and medical sector.
The firm, which was launched in April of la...
Medication outlays top 5.29 trillion won in 2012
The medication costs claimed by Korea’s 69 drug firms came to 5.29 trillion won in 2012, down 6.84 percent from a year earlier, data showed Sunday.
According to the Health Insurance Review and Assessment Service (H...
Pfizer Korea wins lawsuit over Lyrica patent dispute
Pfizer Korea scored another victory in its Lyrica (Pregabalin) patent dispute against Korean generic drug manufacturers, following the court ruling against CJ Cheil Jedang in May.
The Patent Court of Korea ruled th...
KPMA asks government to scrap cash reward system
The Korea Pharmaceutical Manufacturers Association (KPMA) has asked the government to abolish the implementation of the cash reward system for doctors and pharmacists scheduled for January next year.
“We have made ...
Merck drug Janumet XR gains regulatory approval in Korea
MSD Korea announced Thursday that the Ministry of Food and Drug Safety (MFDS) has recently approved Janumet XR (sitagliptin and metformin hydrochloride (HCl) extended-release) tablets, a new treatment for type 2 diabe...
